keyword
https://read.qxmd.com/read/38675484/the-therapeutic-potential-of-four-main-compounds-of-zanthoxylum-nitidum-roxb-dc-a-comprehensive-study-on-biological-processes-anti-inflammatory-effects-and-myocardial-toxicity
#21
JOURNAL ARTICLE
Xiaohan Li, Qi Wang, Ling Liu, Yang Shi, Yang Hong, Wanqing Xu, Henghui Xu, Jing Feng, Minzhen Xie, Yang Li, Baofeng Yang, Yong Zhang
Zanthoxylum nitidum (Roxb.) DC. ( Z. nitidum ) is a traditional Chinese medicinal plant that is indigenous to the southern regions of China. Previous research has provided evidence of the significant anti-inflammatory, antibacterial, and anticancer properties exhibited by Z. nitidum . The potential therapeutic effects and cardiac toxicity of Z. nitidum remain uncertain. The aim of this research was to investigate the potential therapeutic properties of the four main compounds of Z. nitidum in cardiovascular diseases, their impact on the electrical activity of cardiomyocytes, and the underlying mechanism of their anti-inflammatory effects...
April 19, 2024: Pharmaceuticals
https://read.qxmd.com/read/38671900/lycopene-as-a-therapeutic-agent-against-aflatoxin-b1-related-toxicity-mechanistic-insights-and-future-directions
#22
REVIEW
Meng Li, Shusheng Tang, Xinyan Peng, Gaurav Sharma, Shutao Yin, Zhihui Hao, Jichang Li, Jianzhong Shen, Chongshan Dai
Aflatoxin (AFT) contamination poses a significant global public health and safety concern, prompting widespread apprehension. Of the various AFTs, aflatoxin B1 (AFB1) stands out for its pronounced toxicity and its association with a spectrum of chronic ailments, including cardiovascular disease, neurodegenerative disorders, and cancer. Lycopene, a lipid-soluble natural carotenoid, has emerged as a potential mitigator of the deleterious effects induced by AFB1 exposure, spanning cardiac injury, hepatotoxicity, nephrotoxicity, intestinal damage, and reproductive impairment...
April 11, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38671590/nanosponge-for-iron-chelation-and-efflux-a-ferroptosis-inhibiting-approach-for-myocardial-infarction-therapy
#23
JOURNAL ARTICLE
Qingbo Lv, Jun Lin, He Huang, Boxuan Ma, Wujiao Li, Jiawen Chen, Meihui Wang, Xiaoyu Wang, Guosheng Fu, Yun Xiao
Myocardial infarction (MI), a consequence of coronary artery occlusion, triggers the degradation of ferritin, resulting in elevated levels of free iron in the heart and thereby inducing ferroptosis. Targeting myocardial ferroptosis through the chelation of excess iron has therapeutic potential for MI treatment. However, iron chelation in post ischemic injury areas using conventional iron-specific chelators is hindered by ineffective myocardial intracellular chelation, rapid clearance, and high systemic toxicity...
April 26, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38665754/cyclophosphamide-bortezomib-and-dexamethasone-and-severe-systolic-heart-failure-a-case-report
#24
Sagar Pandey, Ernestine Faye S Tan, Amulya Bellamkonda, Binit Aryal, Madhumati Kalavar
Multiple myeloma (MM) is a neoplastic proliferation of plasma cells in bone marrow. Pharmacotherapy for the management of patients with MM includes drug classes like proteasome inhibitors, monoclonal antibodies, immunomodulators, alkylating agents, steroids, etc. We present a case of new-onset heart failure with reduced ejection fraction (HFrEF) in a patient with previously normal ejection fraction after treatment with a cyclophosphamide, bortezomib, and dexamethasone (CyBorD) chemotherapeutic regimen. An echocardiogram done after the completion of nine cycles of chemotherapy in a period of about 4...
March 2024: Curēus
https://read.qxmd.com/read/38664423/a-real-world-pharmacovigilance-study-of-amivantamab-related-cardiovascular-adverse-events-based-on-the-fda-adverse-event-reporting-system-faers-database
#25
JOURNAL ARTICLE
Rui Sun, Zhen Ning, Henan Qin, Wenhe Zhang, Yibin Teng, Chenxing Jin, Jiwei Liu, Aman Wang
Amivantamab is the first dual-specificity antibody targeting EGFR and MET, which is approved for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Cardiovascular toxicities related to amivantamab have not been reported in the CHRYSALIS study. However, the occurrence of cardiovascular events in the real world is unknown. To comprehensively investigate the clinical characteristics, onset times, and outcomes of cardiovascular toxicities associated with amivantamab...
April 25, 2024: Scientific Reports
https://read.qxmd.com/read/38663507/stereo-selective-cardiac-toxicity-induced-by-metconazole-via-oxidative-stress-and-the-wnt-%C3%AE-catenin-signaling-pathway-in-zebrafish-embryos
#26
JOURNAL ARTICLE
Lulu Liu, Fengzhong Wang, Zhong Zhang, Bei Fan, Ying Luo, Lin Li, Yifan Zhang, Zhihui Yan, Zhiqiang Kong, Frédéric Francis, Minmin Li
Metconazole (MEZ), a chiral triazole fungicide, produces enantioselective adverse effects in non-target organisms. Among MEZ's isomers, cis-MEZ displays robust antimicrobial properties. Evaluating MEZ and cis-MEZ's toxicity may mitigate fungicide usage and safeguard non-target organisms. Our study evaluated the toxicity of MEZ and its cis-isomers at concentrations of 0.02, 0.2, 2, and 4 mg·L-1 . We report stereoselectivity and severe cardiovascular defects in zebrafish, including pericardial oedema, decreased heart rate, increased sinus venous and bulbous arteries distances, intersegmental vessel defects, and altered cardiovascular development genes (hand2, gata4, nkx2...
April 23, 2024: Environmental Pollution
https://read.qxmd.com/read/38662859/perfluoroalkyl-polyfluoroalkyl-substances-links-to-cardiovascular-disease-risk
#27
REVIEW
Jennifer J Schlezinger, Noyan Gokce
Conservative estimates by the World Health Organization suggest that at least a quarter of global cardiovascular diseases are attributable to environmental exposures. Associations between air pollution and cardiovascular risk have garnered the most headlines and are strong, but less attention has been paid to other omnipresent toxicants in our ecosystem. Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are man-made chemicals that are extensively used in industrial and consumer products worldwide and in aqueous film-forming foam utilized in firefighting...
April 26, 2024: Circulation Research
https://read.qxmd.com/read/38659494/sunitinib-malate-induces-cell-death-in-adult-human-cardiac-progenitor-cells
#28
JOURNAL ARTICLE
Robert Walmsley, Derek S Steele, Sotiris Papaspyros, Andrew J Smith
Sunitinib malate is known to cause cardiotoxicity in a sub-population of patients, with heart failure seen in more severe cases. Cardiac progenitor cells (CPCs) have been identified in adult human myocardium and contribute to overall tissue maintenance, with previous work identifying negative impacts of sunitinib on these cells. This study aimed to characterise the toxic effects of sunitinib in human CPCs, applying sunitinib concentrations equivalent to clinical plasma levels to these cells in vitro . Cell viability was reduced by 26...
2024: Current research in toxicology
https://read.qxmd.com/read/38652282/2-methoxyestradiol-ameliorates-doxorubicin-induced-cardiotoxicity-by-regulating-the-expression-of-glut4-and-cpt-1b-in-female-rats
#29
JOURNAL ARTICLE
Mohamed H Sobhy, Ahmed Ismail, Mohammed S Abdel-Hamid, Mohamed Wagih, Marwa Kamel
The clinical usage of doxorubicin (DOX) is hampered due to cardiomyopathy. Studies reveal that estrogen (E2) modulates DOX-induced cardiotoxicity. Yet, the exact mechanism is unclear. The objective of the current study is to evaluate the influence of E2 and more specifically its metabolite 2-methoxyestradiol (2ME) on cardiac remodeling and the reprogramming of cardiac metabolism in rats subjected to DOX cardiotoxicity. Seventy-two female rats were divided into groups. Cardiotoxicity was induced by administering DOX (2...
April 23, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38650534/future-perspectives-of-radiation-therapy-for-hodgkin-lymphoma-risk-adapted-response-adapted-and-safer-than-before
#30
REVIEW
Jessica Saddi, Amelia Barcellini, Manuel Gotti, Alessandro Mazzacane, Alessandra Tolva, Tanja Lazic, Luca Arcaini, Marco Zecca, Ester Orlandi, Andrea Riccardo Filippi
Classical Hodgkin lymphoma is a lymphoproliferative disease with a good prognosis mainly seen in young people. Nevertheless secondary malignancy, cardiac disease and infertility may affect the long survivors with significant impact on quality of life, morbidity and overall survival. In the last decades several treatment strategies were evaluated to reduce the toxicity of first line treatment such as avoiding radiotherapy or its reduction in terms of dosage and extension. Many trials including interim Positron Emission Tomography evaluation fail to compare efficacy between combined modality treatment versus chemotherapy alone in particular in early stage disease...
May 2024: Hematological Oncology
https://read.qxmd.com/read/38650478/novel-plga-based-nanoformulation-decreases-doxorubicin-induced-cardiotoxicity
#31
JOURNAL ARTICLE
Nikša Drinković, Maja Beus, Rinea Barbir, Željko Debeljak, Blanka Tariba Lovaković, Nikolina Kalčec, Marija Ćurlin, Ana Bekavac, Dunja Gorup, Ivan Mamić, Dario Mandić, Vedran Micek, Petra Turčić, Nazende Günday-Türeli, Emre Türeli, Ivana Vinković Vrček
Nanotechnology has the potential to provide formulations of antitumor agents with increased selectivity towards cancer tissue thereby decreasing systemic toxicity. This in vivo study evaluated the potential of novel nanoformulation based on poly(lactic- co -glycolic acid) (PLGA) to reduce the cardiotoxic potential of doxorubicin (DOX). In vivo toxicity of PLGADOX was compared with clinically approved non-PEGylated, liposomal nanoformulation of DOX (LipoDOX) and conventional DOX form (ConvDOX). The study was performed using Wistar Han rats of both sexes that were treated intravenously for 28 days with 5 doses of tested substances at intervals of 5 days...
April 23, 2024: Nanoscale
https://read.qxmd.com/read/38649052/perfluoroalkyl-sulfonate-induces-cardiomyocyte-apoptosis-via-endoplasmic-reticulum-stress-activation-and-autophagy-flux-inhibition
#32
JOURNAL ARTICLE
Yuanhao Wang, Da Yin, Xin Sun, Wei Zhang, Huan Ma, Jingnan Huang, Chuanbin Yang, Jigang Wang, Qingshan Geng
Perfluoroalkyl sulfonate (PFOS) is a commonly used chemical compound that often found in materials such as waterproofing agents, food packaging, and fire retardants. Known for its stability and persistence in the environment, PFOS can enter the human body through various pathways, including water and the food chain, raising concerns about its potential harm to human health. Previous studies have suggested a cardiac toxicity of PFOS, but the specific cellular mechanisms remained unclear. Here, by using AC16 cardiomyocyte as a model to investigate the molecular mechanisms potential the cardiac toxicity of PFOS...
April 20, 2024: Science of the Total Environment
https://read.qxmd.com/read/38646095/dihalogenated-nitrophenols-in-drinking-water-prevalence-resistance-to-household-treatment-and-cardiotoxic-impact-on-zebrafish-embryo
#33
JOURNAL ARTICLE
Hongjie Sun, Yingying Liu, Chunxiu Wu, Lena Q Ma, Dongxing Guan, Huachang Hong, Haiying Yu, Hongjun Lin, Xianfeng Huang, Peng Gao
Dihalogenated nitrophenols (2,6-DHNPs), an emerging group of aromatic disinfection byproducts (DBPs) detected in drinking water, have limited available information regarding their persistence and toxicological risks. The present study found that 2,6-DHNPs are resistant to major drinking water treatment processes (sedimentation and filtration) and households methods (boiling, filtration, microwave irradiation, and ultrasonic cleaning). To further assess their health risks, we conducted a series of toxicology studies using zebrafish embryos as the model organism...
June 2024: Eco Environ Health
https://read.qxmd.com/read/38643846/3-methyl-phenanthrene-3-mp-disrupts-the-electrical-and-contractile-activity-of-the-heart-of-the-polar-fish-navaga-cod-eleginus-nawaga
#34
JOURNAL ARTICLE
Tatiana S Filatova, Vladislav S Kuzmin, Irina Dzhumaniiazova, Oksana B Pustovit, Denis V Abramochkin, Holly A Shiels
Alkylated polycyclic aromatic hydrocarbons are abundant in crude oil and are enriched during petroleum refinement but knowledge of their cardiotoxicity remains limited. Polycyclic aromatic hydrocarbons (PAHs) are considered the main hazardous components in crude oil and the tricyclic PAH phenanthrene, has been singled out for its direct effects on cardiac tissue in mammals and fish. Here we test the impact of the monomethylated phenanthrene, 3-methylphenanthrene (3-MP), on the contractile and electrical function of the atria and ventricle of a polar fish, the navaga cod (Eleginus nawaga)...
April 19, 2024: Chemosphere
https://read.qxmd.com/read/38640640/myocardial-injury-in-dogs-a-retrospective-analysis-on-etiological-echocardiographic-electrocardiographic-therapeutic-and-outcome-findings-in-102-cases
#35
JOURNAL ARTICLE
G Romito, L Palatini, M C Sabetti, M Cipone
INTRODUCTION: In dogs, myocardial injury (MI) is a poorly characterized clinical entity; therefore, this study aimed to provide a detailed description of dogs affected by this condition. ANIMALS, MATERIALS, AND METHODS: Dogs diagnosed with MI according to the concentration of cardiac troponin I (cTnI) were retrospectively searched. Signalment, diagnostic, therapeutic, and outcome data were retrieved. Dogs were divided into six echocardiographic (dilated cardiomyopathy phenotype; hypertrophic cardiomyopathy phenotype; hypertrophic cardiomyopathy phenotype with systolic dysfunction; abnormal echogenicity only; endocarditis; and no echocardiographic abnormalities suggestive of MI), four electrocardiographic (abnormalities of impulse formation; abnormalities of impulse conduction; abnormalities of ventricular repolarization; and no electrocardiographic abnormalities suggestive of MI), and nine etiological (infective; inflammatory; neoplastic; metabolic; toxic; nutritional; immune-mediated; traumatic/mechanical; and unknown) categories...
March 30, 2024: Journal of Veterinary Cardiology: the Official Journal of the European Society of Veterinary Cardiology
https://read.qxmd.com/read/38639740/-therapy-na%C3%A3-ve-malignancy-causes-cardiovascular-disease-a-state-of-the-art-cardio-oncology-perspective
#36
REVIEW
Leslie M Ogilvie, Bridget Coyle-Asbil, Keith R Brunt, Jim Petrik, Jeremy A Simpson
Cardiovascular disease (CVD) and cancer are the leading causes of mortality worldwide. Although generally thought of as distinct diseases, the intersectional overlap between CVD and cancer is increasingly evident in both causal and mechanistic relationships. The field of cardio-oncology is largely focused on cardiotoxic effects of cancer therapies (e.g., chemotherapy, radiation). Further, the cumulative effects of cardiotoxic therapy exposure and the prevalence of CVD risk factors in cancer patients leads to long-term morbidity and poor quality of life in this patient population-even when patients are cancer-free...
April 19, 2024: American Journal of Physiology. Heart and Circulatory Physiology
https://read.qxmd.com/read/38637360/protective-effects-of-arbutin-against-doxorubicin-induced-cardiac-damage
#37
JOURNAL ARTICLE
Oguzhan Birdal, Irmak Ferah Okkay, Ufuk Okkay, Cemil Bayram, Behzad Mokthare, Muhammed Sait Ertugrul, Ahmet Hacimuftuoglu, Emrah Aksakal, Yavuzer Koza, Mehmet Saygi, Huseyin Senocak
BACKGROUND: Doxorubicin is an effective antineoplastic agent but has limited clinical application because of its cumulative toxicities, including cardiotoxicity. Cardiotoxicity causes lipid peroxidation, genetic impairment, oxidative stress, inhibition of autophagy, and disruption of calcium homeostasis. Doxorubicin-induced cardiotoxicity is frequently tried to be mitigated by phytochemicals, which are derived from plants and possess antioxidant, anti-inflammatory, and anti-apoptotic properties...
April 18, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38636673/development-of-a-pharmaceutical-database-as-an-aid-to-the-nonclinical-detection-of-drug-induced-cardiac-toxicity
#38
JOURNAL ARTICLE
Donald De Alwis, C Michael Foley, Eugene Herman, Adam P Hill, Peter K Hoffmann, Yasunari Kanda, Emily Kaushik, Jennifer Pierson, Raechel Puglisi, Hong Shi, Xi Yang, Michael K Pugsley
The Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee designed and created a publicly accessible database with an initial set of 128 pharmacologically defined pharmaceutical agents, many with known cardiotoxic properties. The database includes specific information about each compound that could be useful in evaluating hypotheses around mechanisms of drug-induced cardiac toxicity or for development of novel cardiovascular safety assays. Data on each of the compounds was obtained from published literature and online sources (e...
April 16, 2024: Journal of Pharmacological and Toxicological Methods
https://read.qxmd.com/read/38636307/extracorporeal-membrane-oxygenation-ecmo-during-aplasia-a-bridge-towards-myopericarditis-recovery-after-autologous-hematopoietic-stem-cell-transplant-for-systemic-sclerosis-and-recent-coronarovirus-disease-covid-19-vaccination
#39
JOURNAL ARTICLE
Carlotta Cacciatore, Mathilde Baudet, Estelle Jean, Simona Presente, Marylou Para, Romain Sonneville, Dimitri Arangalage, Nassim Ait Abdallah, Flore Sicre de Fontbrune, Pedro Henrique Prata, Benjamin Crichi, Baptiste Hervier, Nathalie Parquet, Gilles Soulat, Elie Mousseaux, Richard K Burt, Dominique Farge
Systemic sclerosis (SSc) is a rare autoimmune disease (AD), characterised by early diffuse vasculopathy, activation of the immune response and progressive skin and internal organ fibrosis. In severe progressive diffuse SSc (dSSc), autologous hematopoietic stem cell transplantation (aHSCT) improves survival, despite its own risk of complications and transplant related mortality (TRM). We present herein the case of a dSSc patient undergoing aHSCT with low dose cyclophosphamide conditioning and sudden acute myopericarditis and cardiogenic shock, four weeks after a second mRNA SARS-CoV-2 vaccine (Pfizer) injection...
April 9, 2024: Current Research in Translational Medicine
https://read.qxmd.com/read/38633023/using-the-consolidated-framework-for-implementation-research-cfir-to-guide-implementation-of-cardio-oncology-services
#40
JOURNAL ARTICLE
Jessica Miller Clouser, Colleen A McMullen, Akosua K Adu, Gretchen Wells, Amit Arbune, Jing Li
INTRODUCTION: Cardio-oncology focuses on diagnosing and preventing adverse cardiovascular outcomes in cancer patients. Interdisciplinary cardio-oncology services address the spectrum of prevention, detection, monitoring, and treatment of cancer patients at risk of cardio-toxicity and aim to improve the continuum of cardiac care for oncology patients. The goal of this study was to engage clinician and administrative stakeholders to assess multilevel needs, barriers, and expectations regarding cardio oncology services...
April 2024: Learning Health Systems
keyword
keyword
106608
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.